CSTL — CASTLE BIOSCIENCES INC

—
Nasdaq · Health Care · Health Care Providers & Services · CIK 1447362 ·
Last close
$32.98
Market Cap
$1.02B
52W High
$44.28
52W Low
$17.72
ADV30
404,523
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 102,891,000 78,972,000 -2,731,000 -4,100,000 579,408,000 77,994,000 100,964,000
Jun 2026 103,546,000 79,846,000 -3,070,000 -2,060,000 561,177,000 62,116,000 91,147,000
Mar 2026 83,679,000 63,146,000 -18,407,000 -14,522,000 547,805,000 63,764,000 86,389,000
Dec 2025 87,010,000 68,695,000 -3,827,000 -2,332,000 578,556,000 116,729,000 107,683,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$42,634,000
Investing CF
$-51,324,000
Financing CF
$-11,427,000
CapEx
$-43,123,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.66
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-240,866,000
Inventory
$10,580,000
Receivables
$48,341,000
ST Investments
$204,689,000
EBIT TTM
$-18,828,000
Pretax Income TTM
$-19,203,000
Interest Exp TTM
$375,000
Analysts
10

Yahoo Snapshot (yfinance, live)

Total Revenue
$377,126,016
EBITDA
$-12,080,000
Free Cash Flow
$5,089,625
Enterprise Value
$761,119,808
Total Cash
$277,664,992
Total Debt
$36,574,000
Shares Out
30,818,291
Trailing EPS
$-0.76
Book Value
$15.55
ROE
-4.9%
ROA
-3.1%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 344,229,000 -42,810,000 -24,158,000 578,556,000 107,683,000 470,873,000 64,347,000
Dec 2024 332,069,000 8,670,000 18,245,000 531,235,000 75,400,000 455,835,000 64,866,000
Dec 2023 219,788,000 -67,977,000 -57,466,000 453,340,000 62,071,000 391,269,000 -5,626,000
Dec 2022 137,039,000 -91,142,000 -67,138,000 447,329,000 48,179,000 399,150,000 -41,655,000

TTM Snapshot

Revenues TTM
$357,278,000
NetIncome TTM
$-19,415,000
OpCashFlow TTM
—
Assets (Latest)
$561,177,000
Forward EPS
$-0.69

Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)

max pain strike: $25.00 · spot: $33.38 · call volume: 6 · put volume: 4

Peers — same industry

TickerNameMarket CapLastDaily %
AHCO AdaptHealth Corp. $1.03B $7.53 —
FRNM Freenome, Inc. $1.09B $9.82 —
OMDA Omada Health, Inc. $872.90M $14.08 —
PNTG Pennant Group, Inc. $1.28B $36.50 —
INNV InnovAge Holding Corp. $1.29B $9.42 —

News headlines (Yahoo Finance, 1h cache)

Castle Biosciences (CSTL) Stock Could Be Undervalued Following Raised 2026 Guidance
2026-11-14 05:17 · Yahoo
Castle Biosciences (CSTL) Lifts Guidance Following Revenue Growth But Is The Valuation Already Priced In
2026-11-13 01:15 · Yahoo
Castle Biosciences Earns 2026 Top Workplaces Awards Recognizing Its People-First Culture
2026-11-12 12:00 · Yahoo
Castle Biosciences to Present at the Piper Sandler 38th Annual Healthcare Conference
2026-11-11 21:30 · Yahoo
DecisionDx®-Melanoma Data at SDPA and Dermato-Onco2026 Support the Test's Ability to Refine Risk Assessment Beyond AJCC Staging
2026-11-11 12:00 · Yahoo
Wall Street Analysts Believe Castle Biosciences (CSTL) Could Rally 37%: Here's is How to Trade
2026-11-10 13:55 · Yahoo
Castle Biosciences Stock Gets A Lift From Raised 2026 Outlook
2026-11-06 18:19 · Yahoo
Castle Biosciences, Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Castle Biosciences Inc (CSTL) (Q3 2026) Earnings Call Highlights: Revenue Jumps 24% as ...
2026-11-06 11:17 · Yahoo
What Castle Biosciences (CSTL) Said on Its Q3 Earnings Call
2026-11-06 03:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.